Monu Kumar Shukla

@shooliniuniversity.com

PhD-JRF Research Scholar
Department of Pharmaceutical Chemistry, School of Pharmaceutical Sciences, Shoolini University

Monu Kumar Shukla


                  Download Compact PDF  
https://researchid.co/mkshukla

EDUCATION

PhD in Pharmaceutical Chemistry (Persuing)

RESEARCH INTERESTS

I'm interested to work in the field of bio nanomaterials, drug delivery, and in silico drug design.
610

Scholar Citations

14

Scholar h-index

19

Scholar i10-index

RECENT SCHOLAR PUBLICATIONS

  • Various Bacterial Secondary Metabolites and Their Roles in Basic Metabolic Processes
    MKS Jyoti Lodhi
    Industrial Applications of Microbial Secondary Metabolites 1, 14 , 2026
    2026
  • Role of Stem Cells in Diabetes, Liver Disease, and Cancer Treatment
    R Kamaraj, MJ Mehran, H Tiwari, MK Shukla, MV Cetiz, Z Basharat, ...
    Handbook of Regenerative Medicine, 404-420 , 2025
    2025
  • Design, synthesis and antiproliferative activity of novel colchicine derivatives: selective inhibition of melanoma cell proliferation
    RSJMHA Puneet Kumar, Tusharika Kotra, Waseem I. Lone I Lone, Yassir Arfath ...
    Frontiers in Pharmacology 16, 1528235 , 2025
    2025
    Citations: 4
  • Assessment of the Phenolics Content in Epilobium angustifolium and Epilobium hirsutum Extracts and Their Pharmacological Activity
    K Uminska, M Korinek, L Ivanauskas, M El‐Shazly, V Georgiyants, ...
    Archiv der Pharmazie 358 (5), e12001 , 2025
    2025
    Citations: 8
  • Computational and Structural Insights into Epilobium Polyphenols Targeting SARS-CoV-2
    DS Ngantung, S Renadi, MK Shukla, O Mykhailenko, M El-Shazly, ...
    2025
  • Zebrafish models for neurological disorders: a platform for natural product-based drug discovery
    A Chauhan, T Raviraj, RC Sobti, A Dutta, MK Shukla, M Korinek
    Frontiers in Natural Products 4, 1679580 , 2025
    2025
    Citations: 1
  • Exploring the role of plants as neuroprotectant and its mode of action
    A Thakur, MK Shukla, S Sharma, S Kumar, A Husain, D Kumar
    Molecular Medicine and Biomedical Research in the Era of Precision Medicine … , 2025
    2025
  • Development and characterization of Myrica esculenta plant extract-based albumin nanoparticles for anticancer activity
    MK Shukla, H Kaushik, H Tiwari, C Behera, RK Tonk, A Husain, J Singh, ...
    Industrial Crops and Products 218, 118815 , 2024
    2024
    Citations: 11
  • Synthesis Strategies of 2D Boron Nanosheets: Computational or Theoretical Route and Experimental Approaches
    MK Shukla, H Tiwari, R Khan
    2D Boron Nanosheets: Synthesis and Applications, 67-81 , 2024
    2024
  • Anticancer Potential of Myrica esculenta Plant: A Comprehensive Review
    MK Shukla, A Sharma, R Kumar, S Pandey, D Kumar
    Handbook of oncobiology: from basic to clinical sciences, 1289-1301 , 2024
    2024
    Citations: 5
  • Application of Single-Cell Sequencing on Stem Cell Research
    S Paul, TP Umar, MK Paul, H Tiwari, MK Shukla, L Kandasami, A Joliholi, ...
    Handbook of Stem Cell Applications, 1131-1156 , 2024
    2024
    Citations: 4
  • Exploring diorganotin (IV) complexes of hydrazone based ligands as multi-target agents: Synthesis, structural characterization, DFT and in vitro biological evaluation
    N Kumar, S Asija, Y Deswal, JS Kirar, D Kumar, DK Jindal, B Basu, ...
    Inorganic Chemistry Communications 161, 112120 , 2024
    2024
    Citations: 19
  • In silico exploration of hypothetical proteins in Neisseria gonorrhoeae for identification of therapeutic targets
    G Lakhanpal, H Tiwari, MK Shukla, D Kumar
    In Silico Pharmacology 12 (1), 10 , 2024
    2024
    Citations: 2
  • Handbook of oncobiology: from basic to clinical sciences
    RC Sobti, NK Ganguly, R Kumar
    Springer , 2024
    2024
    Citations: 23
  • Biodegradable nanocarrier of gemcitabine and tocopherol succinate synergistically ameliorates anti-proliferative response in MIA PaCa-2 cells
    C Behera, KK Sandha, N Banjare, MK Shukla, SM Ali, M Singh, PN Gupta
    International Journal of Pharmaceutics 649, 123599 , 2024
    2024
    Citations: 4
  • In-silico and in-vitro identification of triazole based compounds as potential EGFR inhibitors targeting lung cancer
    S Kumar, MK Shukla, I Ali, F Abbas, R Verma, G Chandra, D Kumar
    Molecular Simulation 49 (17), 1614-1631 , 2023
    2023
    Citations: 11
  • Liposomal systems containing phytochemicals for cancer therapy
    MK Shukla, D Kumar, A Rastogi, SK Sahu
    Proceedings of the International Conference on Materials for Emerging … , 2023
    2023
    Citations: 1
  • Repositioning the Existing Drugs for Neuroinflammation: A Fusion of Computational Approach and Biological Validation to Counter the Parkinson's Disease Progression
    H Tiwari, A Kumar, MR Barik, H Kaur, S Mahajan, MK Shukla, M Gupta, ...
    Molecular Diversity, 1-2 , 2023
    2023
    Citations: 3
  • Antidiabetic evaluation of vanillic acid-glyburide loaded polymeric micelles in high fat diet and streptozotocin induced diabetic rats
    J Kaur, M Gulati, NK Pandey, GL Khatik, S Sudhakar, F Alotaibi, D Kumar, ...
    2023
    Citations: 3
  • Metal‐based nanomaterials and nanocomposites as promising frontier in cancer chemotherapy
    S Kumar, MK Shukla, AK Sharma, GK Jayaprakash, RK Tonk, ...
    MedComm 4 (2), e253 , 2023
    2023
    Citations: 69

MOST CITED SCHOLAR PUBLICATIONS

  • Role and recent advancements of ionic liquids in drug delivery systems
    MK Shukla, H Tiwari, R Verma, WL Dong, S Azizov, B Kumar, S Pandey, ...
    Pharmaceutics 15 (2), 702 , 2023
    2023
    Citations: 94
  • Revisiting the therapeutic potential of gingerols against different pharmacological activities
    S Sharma, MK Shukla, KC Sharma, Tirath, L Kumar, JMH Anal, ...
    Naunyn-schmiedeberg's Archives of Pharmacology 396 (4), 633-647 , 2023
    2023
    Citations: 80
  • Metal‐based nanomaterials and nanocomposites as promising frontier in cancer chemotherapy
    S Kumar, MK Shukla, AK Sharma, GK Jayaprakash, RK Tonk, ...
    MedComm 4 (2), e253 , 2023
    2023
    Citations: 69
  • Potential immunomodulatory activities of plant products
    MK Shukla, SK Singh, S Pandey, PK Gupta, A Choudhary, DK Jindal, ...
    South African Journal of Botany 149, 937-943 , 2022
    2022
    Citations: 36
  • Unravelling the therapeutic potential of orchid plant against cancer
    MK Shukla, Monika, A Thakur, R Verma, H Lalhlenmawia, ...
    South African Journal of Botany 150, 69-79 , 2022
    2022
    Citations: 34
  • Multifunctional GQDs for receptor targeting, drug delivery, and bioimaging in pancreatic cancer
    MK Shukla, A Parihar, C Karththikeyan, D Kumar, R Khan
    Nanoscale, Royal Society of Chemistry (RSC) , 2023
    2023
    Citations: 29
  • Trends of bioderived carbonaceous materials for futuristic biomedical applications
    MK Shukla, WL Dong, S Azizov, KRB Singh, D Kumar, RP Singh, J Singh
    Materials Letters 311, 131606 , 2022
    2022
    Citations: 25
  • A comprehensive review on angel's trumpet (Brugmansia suaveolens)
    S Pundir, MK Shukla, A Singh, R Chauhan, UR Lal, A Ali, D Kumar
    South African Journal of Botany 151, 266-274 , 2022
    2022
    Citations: 24
  • Handbook of oncobiology: from basic to clinical sciences
    RC Sobti, NK Ganguly, R Kumar
    Springer , 2024
    2024
    Citations: 23
  • Assessment of phytochemicals, antioxidants and in-silico molecular dynamic simulation of plant derived potential inhibitory activity of Thalictrum foliolosum DC. and Cordia …
    KK D. Raghuvanshi, S. Kumar, M.K. Shukla, D. Kumar, D. Kumar, R. Verma, E ...
    Biomedicine & Pharmacotherapy 156, 113898 , 2022
    2022
    Citations: 20
  • Exploring diorganotin (IV) complexes of hydrazone based ligands as multi-target agents: Synthesis, structural characterization, DFT and in vitro biological evaluation
    N Kumar, S Asija, Y Deswal, JS Kirar, D Kumar, DK Jindal, B Basu, ...
    Inorganic Chemistry Communications 161, 112120 , 2024
    2024
    Citations: 19
  • Managing apoptosis in lung diseases using nano-assisted drug delivery system
    MK Shukla, A Dubey, S Pandey, SK Singh, G Gupta, P Prasher, ...
    Current Pharmaceutical Design 28 (39), 3202-3211 , 2022
    2022
    Citations: 18
  • Recent advances in strategies for extracellular matrix degradation and synthesis inhibition for improved therapy of solid tumors
    KK Sandha, MK Shukla, PN Gupta
    Current Pharmaceutical Design 26 (42), 5456-5467 , 2020
    2020
    Citations: 18
  • Tumor micro-environment targeted collagenase-modified albumin nanoparticles for improved drug delivery
    MK Shukla, C Behera, S Chakraborty, KK Sandha, A Goswami, PN Gupta
    Journal of Drug Delivery Science and Technology 71, 103366 , 2022
    2022
    Citations: 15
  • Metal-based nanomaterials and nanocomposites as promising frontier in cancer chemotherapy. MedComm 4 (2): e253
    S Kumar, MK Shukla, AK Sharma, GK Jayaprakash, RK Tonk, ...
    2023
    Citations: 12
  • Recent plant-based nanomedicine and nanocarrier for cancer treatment
    MK Shukla, AK Das, A Gaurav, D Bisht, A Singh, D Kumar
    Nanotechnology for drug delivery and pharmaceuticals, 187-206 , 2023
    2023
    Citations: 12
  • Development and characterization of Myrica esculenta plant extract-based albumin nanoparticles for anticancer activity
    MK Shukla, H Kaushik, H Tiwari, C Behera, RK Tonk, A Husain, J Singh, ...
    Industrial Crops and Products 218, 118815 , 2024
    2024
    Citations: 11
  • In-silico and in-vitro identification of triazole based compounds as potential EGFR inhibitors targeting lung cancer
    S Kumar, MK Shukla, I Ali, F Abbas, R Verma, G Chandra, D Kumar
    Molecular Simulation 49 (17), 1614-1631 , 2023
    2023
    Citations: 11
  • Role and application of biocatalysts in cancer drug discovery
    S Sengupta, P Das, S Sharma, MK Shukla, R Kumar, R Kumar Tonk, ...
    Catalysts 13 (2), 250 , 2023
    2023
    Citations: 11
  • Assessment of the Phenolics Content in Epilobium angustifolium and Epilobium hirsutum Extracts and Their Pharmacological Activity
    K Uminska, M Korinek, L Ivanauskas, M El‐Shazly, V Georgiyants, ...
    Archiv der Pharmazie 358 (5), e12001 , 2025
    2025
    Citations: 8